A latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...

Individuals with bariatric surgery, those prescribed an antihyperglycemic medication, and individuals pregnant six months before obesity diagnosis were excluded. A total of 97,456 individuals ...

[2] It is now apparent that the concern about increased ischemic cardiovascular disease risk with diabetes medications, which has been broadly applied by the FDA to all new antihyperglycemic type ...

They found uptake of cardioprotective antihyperglycemic drugs—including glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors—increased over the 10-year study ...